Table 1

Clinicopathological features (n = 155)

n
 %
Age

     ≤ 45 years
 61
 39,4
     > 45 years
 94
 60,6
Tumor size

     ≤ 50 mm
 118
 76,1
     > 50 mm
 37
 23,9
Tumor grade

     1
 17
 11
     2
 98
 63,2
     3
 40
 25,8
Histologic type

     Ductal
 130
 83.8
     Non ductal
 25
 16.1
Lymph node

     Negative
 90
 58,1
     Positive
 65
 41,9
ER expression

     Negative
 63
 40,6
     Positive
 92
 59,4
PR expression

     Negative
 73
 47,1
     Positive
 81
 52,3
HER-2 status

     Negative (score 0, 1, 2+)
 127
 81,9
     Positive (score 3+)
 28
 18,1
Surgery

     MRM
 88*
 81.4*
     BCS
 18*
 16.6*
     MWAC
 2*
 1.8*
Systemic therapy
 92*
 85.1*
Radiotherapy
 76*
 70.3*
Hormone therapy
 46*
 42.5*

HER-2: Human epidermal growth factor receptor 2; ER: Estrogen receptor; PR: Progesterone receptor; MRM: modified radical mastectomy; BCS: breast conserving surgery; MWAC: Mastectomy without axillary clearance. *: n = 108.

Ayadi et al. World Journal of Surgical Oncology 2008 6:112   doi:10.1186/1477-7819-6-112